Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Nectar Lifesciences

Sector: Healthcare | Industry: Drugs & Pharma
R 12.80 0.50  | 4.07% -40.19% 6.00 285.93
NSE Price: Oct 22, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 15:59 12.80 0.50 4.07% 12.65 12.30 100,664 12.35 - 12.90
BSE Oct 22, 2019 12.75 0.46 3.74% 12.57 12.29 9,021 12.55 - 12.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 155,775 P/B: 0.26 NSE Code: NECLIFE
52-Week Range: R 10.90 - 24.30 Dividend Yield: 0.39% BSE Code: 532649
TTM EPS: R 2.12 Book Value: R 49.86 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Nectar Lifesciences -38.01 -9.54 -4.83 -40.19 -29.17 -17.88 -7.57
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of NSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 48.32 18.42 11.18
Net Profit -8.94 -4.26 -5.18
EPS -8.94 -4.26 -5.18
Book Value 4.39 5.02 3.58
Average
Operating Margin 9.71 12.55 13.94
Net Margin 1.71 2.60 3.00
Return on Networth 4.40 5.04 5.61
Return on Investment 10.29 9.71 10.13
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - 7.74 -
Operating Profit - 4.32 -
Net Profit - 3.15 -
EPS - 3.16 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Nectar Lifesciences 285.93 3,081.46 47.62 1.54 4.40 0.26 6.00
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 24, 2019 ARYAN GOYAL  Sell Gift 290,000 13.90 40.31
Jul 24, 2019 SANJIV GOYAL  Buy Gift 290,000 13.90 40.31
Jul 24, 2019 SANJIV HUF  Buy Gift 243,000 13.90 33.78
Jul 24, 2019 SAURABH GOYAL  Sell Gift 243,000 13.90 33.78
Mar 28, 2017 Raman Goyal  Sell Inter-Se Transfer 21,584,000 35.75 7,716.28
Fund Houses invested in the stock
Fund Jun-07 Mar-07 Dec-06 Sep-06 Jun-06
LIC Mutual Fund 0.672 0.672 1.222 1.222 0.657
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Nectar Lifesciences Limited

Address: Village Saidpura, Tehsil Derabassi, SAS Nagar Dist, Punjab - 147001 | Phone: 01762 308000, 308001 | Fax: 01762 281187

Email: [email protected]

Website: www.neclife.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
2.23
Piotroski F-Score
7
Modified C-Score
0
5-Years Price to Earnings
6.01
5-Years Price to Book
0.26
Earnings Yield
EBIT / Enterprise value
17.91%
PEG
Price / Earnings to growth ratio
-0.90
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59